The agency said the crackdown intends to safeguard consumers from drugs for which the FDA cannot verify quality, safety, or efficacy. The Department of Health and Human Services general counsel Mike Stuart, tweeted that the agency had reviewed the matter and referred Hims & Hers to the Department of Justice for investigation for potential violations of the Federal Food, Drug, and Cosmetic Act
These colors help users and healthcare providers ensure the correct dosage is being used
Other GLP-1-RAs are under investigation for their utility in a range of neurodegenerative diseases, such as Alzheimers [13]
Susan Spratt, an endocrinologist and senior medical director for the Population Health Management Office at Duke Health in North Carolina, said that while its clear from the study that tirzepatide is more effective, both medications are still good options for patients because they provide more weight loss than other drugs on the market right now
Baseline Screening: Mandatory blood panels within 30 days of starting treatment